Profile data is unavailable for this security.
About the company
CASI Pharmaceuticals Inc is a holding company principally engaged in developing and commercializing innovative therapeutics and pharmaceutical products. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The Company mainly conducts its business in the domestic market.
- Revenue in USD (TTM)26.85m
- Net income in USD-49.38m
- Incorporated2023
- Employees233.00
- LocationCASI Pharmaceuticals Inc1701-1702, China Central Office Tower 1,BEIJING 100025ChinaCHN
- Phone+86 1 065618789
- Websitehttps://www.casipharmaceuticals.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bon Natural Life Ltd | 18.67m | -1.99m | 10.05m | 96.00 | 18.52 | 0.2302 | -- | 0.5385 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
| Integrated Biopharma Inc | 53.43m | 672.00k | 10.25m | 153.00 | 15.57 | 0.5003 | 10.35 | 0.1919 | 0.0212 | 0.0212 | 1.71 | 0.6597 | 2.07 | 4.45 | 12.77 | 349,183.00 | 2.60 | 9.98 | 3.28 | 13.68 | 9.75 | 10.74 | 1.26 | 4.58 | 1.92 | -- | 0.0072 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -15.77m | 10.30m | 8.00 | -- | -- | -- | -- | -0.600 | -0.600 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -65.57 | -112.46 | -136.47 | -257.78 | -- | -- | -- | -- | -- | -27.77 | 0.0854 | -- | -- | -- | -97.75 | -- | -- | -- |
| Hoth Therapeutics Inc | 0.00 | -12.16m | 11.95m | 2.00 | -- | 1.42 | -- | -- | -1.06 | -1.06 | 0.00 | 0.5442 | 0.00 | -- | -- | 0.00 | -138.61 | -129.47 | -154.67 | -144.30 | -- | -- | -- | -- | -- | -493.48 | 0.00 | -- | -- | -- | -4.37 | -- | -- | -- |
| Cellectar Biosciences Inc | 0.00 | -18.85m | 11.96m | 11.00 | -- | 1.20 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
| Lexaria Bioscience Corp | 522.00k | -10.79m | 16.48m | 7.00 | -- | 2.99 | -- | 31.56 | -0.5743 | -0.5743 | 0.0272 | 0.221 | 0.0659 | -- | 2.97 | 74,571.43 | -136.35 | -102.60 | -145.39 | -105.78 | 100.00 | 87.95 | -2,069.41 | -1,579.38 | -- | -285.30 | 0.00 | -- | 52.05 | 17.53 | -105.37 | -- | 48.50 | -- |
| LakeShore Biopharma Co Ltd | 88.64m | -14.41m | 16.49m | 573.00 | -- | 0.1153 | 2.49 | 0.186 | -0.7458 | -0.7458 | 4.63 | 3.47 | 0.427 | 0.5001 | 1.30 | 154,693.30 | -6.94 | -- | -15.95 | -- | 82.47 | -- | -16.26 | -- | 0.7452 | -2.63 | 0.453 | -- | 7.24 | -- | 76.93 | -- | -- | -- |
| Natural Alternatives International Inc | 134.44m | -11.88m | 19.21m | 293.00 | -- | 0.2783 | -- | 0.1429 | -1.99 | -1.99 | 22.52 | 11.17 | 0.845 | 4.35 | 7.36 | 458,839.60 | -7.47 | 0.4593 | -9.15 | 0.5479 | 8.50 | 12.75 | -8.84 | 0.4296 | 1.01 | -2.56 | 0.1408 | 0.00 | 14.12 | 1.78 | -88.10 | -- | -4.46 | -- |
| CASI Pharmaceuticals Inc | 26.85m | -49.38m | 19.52m | 233.00 | -- | -- | -- | 0.7271 | -2.98 | -2.98 | 1.62 | -1.85 | 0.6096 | 1.60 | 4.22 | 115,218.90 | -107.02 | -36.27 | -277.91 | -51.90 | 53.68 | 57.36 | -175.56 | -124.01 | 0.236 | -13.27 | -- | -- | -15.77 | 47.19 | -45.62 | -- | -55.67 | -- |
| Global Pharmatech Inc. | 3.18m | -2.24m | 20.76m | 217.00 | -- | 0.1459 | -- | 6.53 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
| Nutraproducts Inc | 0.00 | -821.94k | 20.92m | 0.00 | -- | 3.50 | -- | -- | -1.31 | -1.31 | 0.00 | 0.2973 | 0.00 | -- | -- | -- | -513.70 | -1,177.23 | -740.45 | -- | -- | -- | -- | -- | -- | -385.17 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Dare Bioscience Inc | 27.69k | -17.46m | 24.01m | 21.00 | -- | 8.19 | -- | 866.95 | -1.92 | -1.92 | 0.0029 | 0.2052 | 0.0011 | -- | 0.0624 | 1,318.57 | -71.56 | -91.64 | -241.96 | -243.93 | 127.70 | -- | -63,069.55 | -1,024.05 | -- | -156.39 | 0.7177 | -- | -99.65 | -- | 86.56 | -- | -- | -- |
| Aytu Biopharma Inc | 63.70m | -13.31m | 24.69m | 82.00 | -- | 0.9839 | -- | 0.3876 | -2.27 | -2.24 | 5.93 | 2.34 | 0.529 | 1.89 | 2.26 | 776,780.50 | -11.05 | -26.47 | -23.44 | -47.32 | 67.56 | 60.56 | -20.90 | -52.54 | 1.08 | 0.3443 | 0.5398 | -- | 1.84 | 19.16 | -13.27 | -- | -- | -- |
| TherapeuticsMD Inc | 2.80m | 73.00k | 25.35m | 1.00 | 350.96 | 0.9236 | 55.10 | 9.07 | 0.0062 | 0.0261 | 0.2419 | 2.37 | 0.0715 | -- | 0.8002 | 2,796,000.00 | 0.1867 | -42.65 | 0.2169 | -112.14 | -- | -- | 2.61 | -193.47 | -- | -5,240.00 | 0.00 | -- | 35.25 | -48.72 | 69.97 | -- | -- | -- |
| Medicus Pharma Ltd | -100.00bn | -100.00bn | 27.37m | -- | -- | -- | -- | -- | -- | -- | -- | -0.0434 | -- | -- | -- | -- | -- | -361.95 | -- | -- | -- | -- | -- | -- | -- | -- | 1.13 | -- | -- | -- | -109.90 | -- | -- | -- |
| SCYNEXIS Inc | 2.93m | -25.30m | 28.97m | 28.00 | -- | 0.7951 | -- | 9.88 | -0.5107 | -0.5107 | 0.0593 | 0.8683 | 0.0391 | -- | 0.5776 | 104,714.30 | -33.71 | -20.51 | -43.65 | -24.97 | 33.32 | -- | -862.89 | -64.82 | -- | -- | 0.00 | -- | -97.33 | 98.68 | -131.75 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to CASI Pharmaceuticals Inc's reporting currency: US Dollar USD
3.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BofA Securities, Inc.as of 30 Sep 2025 | 254.82k | 1.24% |
| Woodline Partners LPas of 30 Sep 2025 | 165.64k | 0.81% |
| Wellington Shields Capital Management LLCas of 30 Sep 2025 | 69.54k | 0.34% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 43.90k | 0.21% |
| Two Sigma Investments LPas of 30 Sep 2025 | 33.27k | 0.16% |
| Wellington Shields & Co. LLC (Investment Management)as of 30 Sep 2025 | 30.09k | 0.15% |
| Geode Capital Management LLCas of 30 Sep 2025 | 18.81k | 0.09% |
| Ground Swell Capital LLCas of 30 Sep 2025 | 10.14k | 0.05% |
| Brewin Dolphin Wealth Management Ltd.as of 30 Sep 2025 | 9.70k | 0.05% |
| Group One Trading LLCas of 30 Sep 2025 | 2.30k | 0.01% |
More ▼
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
